Skip to main content
Equibles

Nir Sassi

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Nir Sassi

Earlier roles on record: CFO at Indaptus Therapeutics, Inc. (INDP) until April 1, 2026. Indaptus Therapeutics, Inc. reported in an 8-K filed April 3, 2026 that Nir Sassi resigned as Chief Financial Officer, effective April 1, 2026.

“Nir Sassi resigned as Chief Financial Officer on April 1, 2026.”
Indaptus Therapeutics, Inc. Form 8-K, filed April 3, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.